This is to acknowledge that Giuseppe Cotellessa Attended a one-hour webinar and Q&A session entitled " Monoclonal protein testing: Clinical utility, challenges & opportunities " / Con la presente si attesta che Giuseppe Cotellessa ha partecipato ad un webinar di un'ora con sessione di domande e risposte dal titolo: "Test delle proteine monoclonali: utilità clinica, sfide ed opportunità"/#9/11/2026
This is to acknowledge that
Giuseppe Cotellessa
Attended a one-hour webinar and Q&A session entitled
" Monoclonal protein testing: Clinical utility, challenges & opportunities " /
Con la presente si attesta che
Giuseppe Cotellessa
ha partecipato ad un webinar di un'ora con sessione di domande e risposte dal titolo:
"Test delle proteine monoclonali: utilità clinica, sfide ed opportunità"/#9/11/2026
Dott. Giuseppe Cotellessa
Monoclonal protein testing: Clinical utility, challenges & opportunities
Diagnosing and monitoring plasma cell disorders presents ongoing challenges for clinical laboratories. While serum protein electrophoresis (SPEP), immunofixation electrophoresis (IFE), and serum free light chain (sFLC) testing remain central to monoclonal protein assessment, issues such as therapeutic monoclonal antibody interference, antigen excess, and complex result interpretation can impact diagnostic confidence and patient management.
Join our expert speaker, Stephanie Brunelle, PhD, for an accredited webinar exploring the clinical utility of conventional monoclonal protein testing methods, the limitations that laboratorians encounter in routine practice, and the emerging role of mass spectrometry in monoclonal protein detection and characterization.
Attendees will gain a balanced perspective on current best practices, analytical pitfalls, and future directions in monoclonal protein testing that may improve diagnostic confidence and support optimal patient care.
ITALIANO

Commenti
Posta un commento